Drugmaker Granules to tighten oversight after US FDA warning, executive says

The company, which is globally one of the largest paracetamol makers and a major player in the active pharmaceutical ‌ingredients market, derives ⁠a ⁠bulk of its revenue from the US.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/40fa8S5
via IFTTT